Surface-Conjugated DiaCEST Nanoparticles for MRI Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanocarriers face challenges in efficiently incorporating diamagnetic Chemical Exchange Saturation Transfer (diaCEST) agents, particularly hydrophilic ones, due to the hydrophobic nature of polymeric particles, which limits proton exchange and CEST contrast, necessitating the development of nanocarriers that can effectively load and track diaCEST agents in vivo during chemotherapy.
Innovation Solution
Surface-conjugated diaCEST agent carriers, including micro- and nanoparticles with biocompatible polymer cores and hydrophilic coatings, such as PEG, that allow for efficient proton exchange and tracking, and liposomes with PEG-conjugated lipids for enhanced imaging and mucus penetration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If hydrophilic diaCEST contrast agents are encapsulated in polymeric nanoparticles with hydrophobic cores, then the particles can be designed to encapsulate lipophilic drugs, but the loading efficiency of hydrophilic compounds is highly restricted
Solution Approach 1:
The patent applies local quality by creating distinct regions within the nanoparticle with different hydrophilicities. The core remains hydrophobic for drug encapsulation, while the shell or surface is made hydrophilic through coating with materials like polyethylene glycol (PEG) or incorporation of hydrophilic polymers. This spatial differentiation of properties allows simultaneous optimization for both lipophilic drug loading in the core and hydrophilic diaCEST agent incorporation in the shell, resolving the contradiction between these two requirements.
2Reliability
If diaCEST agents are loaded into polymeric particles, then the particles can provide imaging capability, but the access of agents to water molecules is severely curtailed due to limited permeation of water into the particles, thereby diminishing the CEST contrast
Solution Approach 1:
The patent introduces water-permeable materials as intermediaries between the hydrophobic polymeric core and the external aqueous environment. These materials form a shell or matrix that allows water molecules to penetrate through to reach the diaCEST agents while maintaining the structural integrity and hydrophobic drug-loading capability of the core. This intermediary layer enables the proton exchange mechanism required for CEST contrast without compromising particle stability or drug encapsulation.
3Measurement precision
If conventional paramagnetic or superparamagnetic metal-based MRI contrast agents are used, then strong imaging signal is achieved, but toxicity increases and biocompatibility decreases
Solution Approach 1:
The patent applies parameter changes by transitioning from metal-based paramagnetic or superparamagnetic contrast agents to non-metallic diaCEST-based contrast agents. This fundamental change in the chemical composition parameter eliminates the toxicity associated with metal accumulation while maintaining imaging functionality through a different physical mechanism (chemical exchange saturation transfer). The diaCEST agents typically use abundant elements like zinc or manganese at low concentrations, or even non-metallic protons, thereby improving biocompatibility while providing sufficient imaging contrast.
4Adaptability or versatility
If multiple types of nanoparticles are used for different therapeutic purposes, then treatment versatility is improved, but the ability to simultaneously track different particle types in vivo becomes difficult
Solution Approach 1:
The patent applies the color changes principle by developing a suite of diaCEST contrast agents with distinct chemical structures that exhibit different chemical shift frequencies in NMR/MRI spectra. Each agent type produces a unique spectral signature or 'color' in the frequency domain, allowing multiple nanoparticle types to be simultaneously tracked in vivo through their distinctive spectral fingerprints. This enables multiplexed imaging where different therapeutic nanoparticles can be monitored concurrently without signal interference.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These carriers enable simultaneous monitoring of multiple particle types with improved biocompatibility and imaging capabilities, facilitating effective tracking and monitoring of nano-carriers in vivo, while maintaining stability and preventing aggregation.
Implementation Method 1
Surface conjugated diamagnetic Chemical Exchange Saturation Transfer (diaCEST) agent carriers and methods of making and using are described herein
Implementation Method 2
The hydrophilic material on the surface can act as a spacer to enable effective diaCEST imaging of the particles
Implementation Method 3
In some embodiments, the particles and/or liposomes are mucus penetrating. In other embodiments, the particles and/or liposomes are not mucus penetrating.
Data Source
AI summary
Surface conjugated diamagnetic Chemical Exchange Saturation Transfer (diaCEST) agent carriers and methods of making and using are described herein. The particles are safe alternatives to conventional paramagnetic or superparamagnetic metal-based MRI contrast agents that are often toxic and therefore not biocompatible. The carriers described herein can provide simultaneous monitoring of multiple particle types labeled with ‘multicolor’ diaCEST contrast agents. In some embodiments, the carriers are micro- and/or nanoparticles. In other embodiments, the carriers are liposomes. In some embodiments, the particles and/or liposomes are mucus penetrating. In other embodiments, the particles and/or liposomes are not mucus penetrating.